France· FR:66887122
AMVUTTRA 25 mg, solution injectable en seringue préremplie
A vutrisiran product containing vutrisiran sodique, registered in France by ALNYLAM NETHERLANDS (PAYS-BAS), on the national reimbursement list. The same ATC class is registered in 14 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Vutrisiran is registered in 14 of 19 countries.
Countries holding a registration under ATC N07XX18 (vutrisiran), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 8 of them publish a price we can compare per daily dose
Vutrisiran · ATC N07XX18
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of vutrisiran costs, country by country.
Normalised to the WHO defined daily dose (0.278 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Vutrisiran · price per daily dose (0.278 mg)
USD · FX 28 Sept 2026
- CH Switzerland$1135.51
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- VUTRISIRAN SODIQUE
- Manufacturer
- ALNYLAM NETHERLANDS (PAYS-BAS)
- Country
- France (FR)
- ATC code
- N07XX18
- ATC class
- Vutrisiran
- Defined daily dose
- 0.278 mg, P
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip1334009302604941 seringue(s) préremplie(s) en verre de 0,5 ml avec protège-aiguilleEUR 66.6
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Vutrisiran in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsAmvuttra 25mg, oplossing voor injectie in voorgevulde spuitAlnylam Netherlands B.V.
- SpainAMVUTTRA 25 MG SOLUCION INYECTABLE EN JERINGA PRECARGADAAlnylam Netherlands B.V.
- SwitzerlandAmvuttra
- United KingdomAmvuttra 25mg/0.5ml solution for injection pre-filled syringesAlnylam UK Ltd
- IcelandAmvuttraAlnylam Netherlands B.V.
- PolandAmvuttraAlnylam Netherlands B.V.
- CanadaAMVUTTRAALNYLAM NETHERLANDS B.V.
- SwedenAmvuttra 25 mg Injektionsvätska, lösning i förfylld sprutaAlnylam Netherlands B.V.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Amvuttra
- Liechtenstein · Amvuttra
- Norway · Amvuttra
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/80980d86-3199-4478-a24e-f1babf6d78f3 GET /v1/drugs/80980d86-3199-4478-a24e-f1babf6d78f3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "66887122",
"date_amm": "2022-09-15",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/22/1681",
"substance": "VUTRISIRAN SODIQUE",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution injectable",
"voies_administration": "sous-cutanée",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Oui"
}See everything about vutrisiran.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.